SCHEMBL426782

SCHEMBL426782

C=CC(=O)NCCCCCCCCCCCCCCCCCCCCCC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ZDHHC20 Q5W0Z9 3/20 1.00
ZDHHC2 Q9UIJ5 3/20 1.00
EPHX1 P07099 9/20 0.59
CASP2 P42575 1/20 0.53
EGFR P00533 1/20 0.50
NAAA Q02083 1/20 0.50
ALDH1A1 P00352 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
FAAH O00519 1/20 0.47
TGM2 P21980 1/20 0.46
THRA P10827 1/20 0.46
THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16193831 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL220516 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL14857206 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL890059 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL346798 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL25793 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL17183678 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL10820746 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL8087553 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL719563 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 407 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240317919-A1 BLOCK COPOLYMERS DERIVED FROM SHORT AND LONG ALKYL CHAIN ACRYLATES OR ACRYLAMIDES AND APPLICATIONS THEREOF ISP INVESTMENTS LLC 2024-09-26 US claimed
US-20240117098-A1 BLOCK COPOLYMERS DERVIED FROM SHORT AND LONG ALKYL CHAIN ACRYLATES OR ACRYLAMIDES AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2024-04-11 US claimed
WO-2022235555-A1 BLOCK COPOLYMERS DERIVED FROM SHORT AND LONG ALKYL CHAIN ACRYLATES OR ACRYLAMIDES AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2022-11-10 WO claimed
CN-114539476-A Graft copolymerization high polymer material with viscoelasticity and preparation method thereof 东营市大用石油助剂有限责任公司 2022-05-27 CN claimed
EP-1652825-B9 Method for producing Hydrophobically modified polymers AKZO NOBEL NV (NL) 2011-02-23 EP claimed
EP-1652825-B1 Method for producing Hydrophobically modified polymers AKZO NOBEL NV (NL) 2010-09-15 EP claimed
EP-4067466-B1 WASHING OR CLEANING AGENT HENKEL AG & CO KGAA (DE) 2026-05-20 EP disclosed
EP-4143289-B1 HIGHLY ALKALINE TEXTILE WASHING AGENT COMPRISING PROTEASE HENKEL AG & CO KGAA (DE) 2026-05-06 EP disclosed
EP-4448706-B1 HOME CARE COMPOSITION COMPRISING AN AMYLASE PROCTER & GAMBLE (US) 2026-04-08 EP disclosed
EP-2721149-B2 DISHWASHING DETERGENT WITH BLEACHING CATALYST AND PROTEASE HENKEL AG & CO KGAA (DE) 2026-04-08 EP disclosed
US-12595441-B2 Automatic dishwashing composition comprising a protease THE PROCTER & GAMBLE COMPANY (US) 2026-04-07 US disclosed
US-12570931-B2 Dishwashing agent with bleaching catalyst and Bacillus gibsonii protease HENKEL AG & CO. KGAA (DE) 2026-03-10 US disclosed
US-12516272-B2 Cleaning agent comprising protease for automatic dosing HENKEL AG & CO. KGAA (DE) 2026-01-06 US disclosed
US-6369249-B1 Process for the preparation of N-substituted acrylamides COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2002-04-09 US disclosed
EP-0953358-A1 Use of coplymers comprising N-Vinyllactam and/or N-Vinylamine as matrix for preparing solid pharmaceutical and/or application forms BASF AKTIENGESELLSCHAFT (DE) 1999-11-03 EP disclosed
EP-0910351-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-28 EP disclosed
EP-0907666-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-14 EP disclosed
WO-1997049736-A2 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed
WO-1997049387-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed
US-4870137-A AMIDATED POLYACRYLIC ACID SOCIETE NATIONALE ELF AQUITAINE (FR) 1989-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240117098-A1 BLOCK COPOLYMERS DERVIED FROM SHORT AND LONG ALKYL CHAIN ACRYLATES OR ACRYLAMIDES AND APPLICATIONS THEREOF C3AR1, C5, C1R ZDHHC20 970/4885ZDHHC2 2347/4885EPHX1 2702/4885
US-20240317919-A1 BLOCK COPOLYMERS DERIVED FROM SHORT AND LONG ALKYL CHAIN ACRYLATES OR ACRYLAMIDES AND APPLICATIONS THEREOF C3AR1, C5, C1R ZDHHC20 1404/4885ZDHHC2 3245/4885EPHX1 2274/4885
US-12595441-B2 Automatic dishwashing composition comprising a protease DPEP1, CTRL, MMP1 ZDHHC20 2322/4885ZDHHC2 1630/4885EPHX1 2647/4885
US-12570931-B2 Dishwashing agent with bleaching catalyst and Bacillus gibsonii protease SEC11A, PRTN3, PRSS2 ZDHHC20 2424/4885ZDHHC2 1812/4885EPHX1 2502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.